OneAscent Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$434K Buy
2,770
+200
+8% +$30K 0.02% 412
2026
Q1
$392K Buy
+2,570
New +$394K 0.02% 394
2025
Q3
Sell
-2,156
Closed -$264K 502
2025
Q2
$264K Sell
2,156
-122
-5% -$13.8K 0.02% 443
2025
Q1
$251K Buy
2,278
+97
+4% +$10.3K 0.02% 429
2024
Q4
$212K Sell
2,181
-26
-1% -$2.77K 0.02% 442
2024
Q3
$254K Sell
2,207
-35
-2% -$3.97K 0.18% 146
2024
Q2
$239K Sell
2,242
-64
-3% -$6.42K 0.03% 215
2024
Q1
$223K Buy
2,306
+43
+2% +$4.41K 0.02% 346
2023
Q4
$229K Buy
+2,263
New +$218K 0.03% 320

Other funds holding NVS

OneAscent Financial Services's NVS Position: Q2 2026 in Review

OneAscent Financial Services increased its Novartis (NVS) stake by 7.8% in Q2 2026, buying an estimated $30K and bringing the position to 2,770 shares worth $434K. The position accounts for 0.02% of the portfolio, ranked #412.

OneAscent Financial Services first reported a position in NVS in Q4 2023 and has held it in 9 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • OneAscent Financial Services held 2,770 shares of Novartis worth $434K as of Q2 2026.
  • OneAscent Financial Services bought 200 Novartis shares in Q2 2026, an estimated $30K.
  • Novartis made up 0.02% of OneAscent Financial Services's portfolio in Q2 2026, its #412 holding.
  • OneAscent Financial Services first reported a position in Novartis in Q4 2023 and has held it in 9 quarters since.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on OneAscent Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.